The company has developed an innovative and patented technology that allows clinicians to perform minimally invasive intervention through a short transverse incision to the neck. Key benefits include much less pain and faster recovery than current approaches. Secondary benefits may include reduced blood loss, lower rates of transfusion/infection and much shorter hospital stay. The technology aims to provide both improved clinical outcome for patients and economic savings for healthcare providers.

The company’s CoreVista® device has been successfully used in both surgical and transcatheter aortic valve replacement procedures. Other cardiovascular applications are envisaged with similar benefits for patients and healthcare providers.

Find out more about CardioPrecision.